Senseonics
Company Snapshot
Founded: 1996
Entity Type: Public
Employees: 117
Region: U.S.
Revenue: $22.5 Millions
Revenue Year: 2024
Headquarter: Maryland, U.S.
Key Geographics: U.S.
Corporate Address: 20451 Seneca Meadows Parkway Germantown, Maryland 20876-7005 U.S. Tel. +1-301-515-7260 www.senseonics.com
Company Overview
Senseonics Holdings Inc. is a medical technology company that manufactures advanced, long-term implantable glucose management products. The Eversense CGM system, including the Eversense E3 model, is designed to deliver continuous and precise glucose monitoring for people with diabetes. Unlike traditional CGM systems that need replacement every 7 to 14 days, the Eversense E3 provides extended usability for up to six months. The company operates only with one segment, glucose monitoring products.
Financial Highlights (FY 2024)
Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***
This information is available for BCC Research members only.
Senseonics In News
Company's Business Segments
- Product Sales : We generate the majority of our product revenue from sales of the Eversense system and related components and supplies to Ascensia
Applications/End User Industries
- Patients
- Hospitals
- Pharmacies
- Clinics
- Strategic Fulfillment Partners
- Health Care Providers
- Helath Care Centers
- Warehousing
BCC Research Beacon 